Date Title
Feb 14, 2013 FDA Grants Diazyme 510(k) Clearance to Market Its D-Dimer Assay for Clinical Chemistry Analyzers
Jan 08, 2013 FDA Grants Diazyme 510(k) Clearance to Market its New 25-Hydroxy Vitamin D Enzyme Immunoassay
Nov 09, 2012 FDA Grants Diazyme Clearance to Market a New Biomarker for Early Detection of Kidney Disease, on the SMART Point of Care System
May 25, 2011 Diazyme Receives 510(k) FDA Approval for Enzymatic Glycated Serum Protein (Glycated Albumin) Assay Kit
Jan 24, 2011 Diazyme Receives FDA 510(k) Clearance for Vitamin D Assay
May 07, 2010 Diazyme Receives FDA 510(k) Clearance to Market SMART HbA1c Assay on Its SMART Point of Care System for Diabetes Monitoring
Jul 20, 2009 Diazyme homocysteine Test Receives AACC Award
Dec 15, 2008 Diazyme Introduces Liquid Stable Enzymatic Lithium Test
May 13, 2008 Federal Circuit Affirms Ruling That Diazyme's Homocysteine Assay Does Not Infringe Axis-Shield's Patents
Mar 06, 2008 Diazyme Receives FDA 510(k) Clearance for HDL-Cholesterol Assay
Mar 06, 2008 Diazyme Receives FDA 510(k) Clearance for LDL-Cholesterol Assay
Feb 26, 2008 Diazyme Introduces New Test for the Early Detection of Kidney Disease
May 03, 2007 Diazyme Receives FDA 510(k) Clearance for Low Cost Enzymatic Creatinine Assay
Apr 19, 2007 Diazyme Receives FDA Approval and NGSP Certification for Its Direct Enzymatic HbA1c Assay Product
Apr 11, 2007 Diazyme Laboratories Is Granted Second Summary Judgment of Noninfringement Regarding Homocysteine Assay Patents

    1 2     »»